| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 9327516 | Gynecologic Oncology | 2005 | 7 Pages |
Abstract
Only p53 overexpression seems to influence overall survival although, due to the small number of patients studied, no safe conclusions can be drawn. Despite the predominance of early stage patients that favorably influenced overall survival, aggressive surgical cytoreduction followed by anthracycline-based treatment were the cornerstone in our multimodality approach.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Obstetrics, Gynecology and Women's Health
Authors
Markella-P. Zorzou, Sophia Markaki, Alexandros Rodolakis, Efstathios Kastritis, Georgios Bozas, Meletios A. Dimopoulos, Christos A. Papadimitriou,